AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Iklo SP 50mg/325mg Tablet

Prescription Icon
Prescription Required

Marketer

Ani Healthcare Pvt Ltd

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg)

Overview Iklo SP 50mg/325mg Tablet

Rheumacin 50mg/325mg tablets offer effective pain management. This medication targets pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It also provides relief from muscle aches, back pain, dental pain, and ear, nose, and throat discomfort. Rheumacin 50mg/325mg tablets should be administered with food to minimize gastrointestinal upset. Adhere strictly to your physician's prescribed dosage and duration. Exceeding the recommended dose or duration may be harmful. Potential side effects include nausea, vomiting, abdominal pain, appetite suppression, indigestion, and diarrhea. Report any persistent or bothersome side effects to your doctor, who can advise on mitigating strategies. Prior to commencing treatment, inform your doctor of any pre-existing heart, kidney, liver conditions, or stomach ulcers. Furthermore, disclose all other medications currently being used to ensure safe and effective treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding.

Uses of Iklo SP 50mg/325mg Tablet

Analgesia

Major Benefits of Iklo SP 50mg/325mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Iklo SP 50mg/325mg Tablet with a meal.

Common Side effects of Iklo SP 50mg/325mg Tablet:

  • Nausea
  • Vomiting
  • Stomach pain/epigastric pain
  • Heartburn
  • Diarrhea
  • Loss of appetite

How to use Iklo SP 50mg/325mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/325mg Iklo SP Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Iklo SP 50mg/325mg Tablet works:

Diclofenac and Paracetamol, combined in Iklo SP 50mg/325mg tablets, alleviate pain, fever, and inflammation by inhibiting the body's pain-signaling chemicals.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Iklo SP 50mg/325mg Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Iklo SP 50mg/325mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Iklo SP 50mg/325mg tablets safely. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Iklo SP 50mg/325mg Tablets, which can induce side effects such as headaches, blurred vision, dizziness, or drowsiness in certain individuals.

KidneyKidneyCAUTION

Patients with kidney impairment should use Iklo SP 50mg/325mg tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use the 50mg/325mg Iklo SP tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. This medication is contraindicated for individuals experiencing severe or active liver disease.

What if you forget to take Iklo SP 50mg/325mg Tablet :

Should you forget to take your Iklo SP 50mg/325mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Iklo SP 50mg/325mg Tablet

LabelValue
Potential for Dependence None.
Medication Category Pain relievers

FAQs on Iklo SP 50mg/325mg Tablet

Each Iklo SP 50mg/325mg tablet combines diclofenac and paracetamol to alleviate pain and inflammation. This effect is achieved by reducing the body's production of pain- and inflammation-causing chemicals. Paracetamol's rapid action provides initial symptom relief until the diclofenac becomes fully effective.
Iklo SP 50mg/325mg Tablets are generally well-tolerated. Nevertheless, some individuals may experience adverse reactions, including common side effects such as nausea, vomiting, abdominal pain, heartburn, and diarrhea, as well as less frequent or infrequent side effects. Report any ongoing issues to your physician during treatment.
Continued use of Iklo SP 50mg/325mg Tablets for chronic pain management should follow your doctor's instructions. For acute pain, the medication may be stopped once the pain subsides.
Nausea and vomiting are possible side effects of Iklo SP 50mg/325mg Tablets. Consuming the tablets with milk, food, or antacids may mitigate nausea. Fatty or fried foods should be avoided while taking this medication. If vomiting occurs, replenish fluids by sipping small amounts of water or other liquids frequently. Persistent vomiting accompanied by dehydration symptoms, such as dark, strong-smelling urine and infrequent urination, warrants immediate medical attention. Consult your physician before taking any other medications.
Some individuals taking Iklo SP 50mg/325mg Tablets may experience dizziness, characterized by faintness, weakness, unsteadiness, or lightheadedness. Should dizziness occur, rest is recommended until symptoms subside.
Chronic administration of Iklo SP 50mg/325mg tablets can indeed impair kidney function. Healthy kidneys synthesize prostaglandins, chemicals crucial for their protection. Analgesic use diminishes prostaglandin production, increasing the risk of renal damage with prolonged consumption. Individuals with pre-existing kidney conditions should avoid using such painkillers.
Patients with a known hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) or any constituent of Iklo SP 50mg/325mg Tablet should not take this medication. The medication is contraindicated in individuals with a history of peptic ulcers or active gastrointestinal bleeding. Furthermore, its use should be avoided in those with a history of cardiac insufficiency, hypertension, or hepatic or renal impairment.
Confirmation: Concurrent use of Iklo SP 50mg/325mg tablets and vitamin B-complex supplements is permissible. The analgesic properties of Iklo SP 50mg/325mg tablets address pain symptoms, while the vitamin B-complex formulation may address any vitamin deficiencies contributing to the pain.
Exceeding the prescribed dosage of Iklo SP 50mg/325mg Tablets elevates the risk of adverse reactions such as nausea, vomiting, heartburn, dyspepsia, and diarrhea. Prolonged use of higher than recommended doses may also result in kidney damage. For persistent or worsening pain unrelieved by the standard dosage, seek medical advice for reassessment.
Retain this medication within its original, sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Iklo SP 50mg/325mg Tablet
67
MRP 82
18% off